Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 13,029 shares at $19.75 ($258K) on 2025-07-07, disclosed to the SEC on 2025-07-09.
Scheduled sale ($258k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.75 | 6,362 | $126K | 48.8% |
| 2 | $19.75 | 6,362 | $126K | 48.8% |
| 3 | $20.69 | 305 | $6K | 2.4% |
| Total | $19.77 avg | 13,029 | $258K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |